Product Program year 2021 Source: CMS Open Payments

Advance

Device Stress Urinary Incontinence

Open in the dashboard

General payments

$267,969

400 payments

Research payments

$0

0 payments

Through program year 2021, $267,969 in general payments and $0 in research payments were reported against Advance (Stress Urinary Incontinence).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2021 General $120 2
2020 General $137,273 113
2019 General $130,575 285

Breakdown

Who paid General payments · program years 2019–2021
  1. Boston Scientific Corporation $267,969 400 payments
Top recipients General payments · program year 2020
  1. L Knoll Urology · Nashville, TN $29,476 21% · 6 payments
  2. Edward Karpman Urology · Mountain View, CA $24,058 18% · 4 payments
  3. Andrew Peterson Urology · Durham, NC $19,962 15% · 3 payments
  4. Kurt McCammon Urogynecology and Reconstructive Pelvic Surgery · Virginia Beach, VA $16,316 12% · 5 payments
  5. Mohit Khera Urology · Houston, TX $11,830 9% · 2 payments

The top 5 of 75 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Urology $117,397 87% · 65 practitioners
  2. Urogynecology and Reconstructive Pelvic Surgery Urology $16,316 12% · 1 practitioner
  3. Interventional Cardiology Internal Medicine $407 <1% · 1 practitioner
  4. Surgery $58 <1% · 3 practitioners
  5. Emergency Medicine $13 <1% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Tennessee $29,476 21% · 1 recipient
  2. North Carolina $29,464 21% · 9 recipients
  3. Texas $25,012 18% · 4 recipients
  4. California $24,071 18% · 2 recipients
  5. Virginia $16,316 12% · 1 recipient

The top 5 of 22 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

400 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record